Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitro study

[1]  J. Cook,et al.  Nonsteroidal antiinflammatory drugs: a review. , 2005, Journal of the American Animal Hospital Association.

[2]  J. Bijlsma,et al.  Selective COX-2 inhibition is favorable to human early and late-stage osteoarthritic cartilage: a human in vitro study. , 2005, Osteoarthritis and cartilage.

[3]  P. Dieppe,et al.  Pathogenesis and management of pain in osteoarthritis , 2005, The Lancet.

[4]  B. Aggarwal,et al.  Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation , 2004, Oncogene.

[5]  T. Schnitzer,et al.  Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial , 2004, The Lancet.

[6]  R. Willburger,et al.  Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro. , 2004, Osteoarthritis and cartilage.

[7]  M. Lazzaroni,et al.  Gastrointestinal side‐effects of traditional non‐steroidal anti‐inflammatory drugs and new formulations , 2004, Alimentary pharmacology & therapeutics.

[8]  J. Mitchell,et al.  Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  W. Li,et al.  Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. , 2004, Cellular signalling.

[10]  P. Delafontaine,et al.  Nonsteroidal anti-Inflammatory drugs and cardiovascular risk. , 2004, Journal of the American College of Cardiology.

[11]  J. Devogelaer,et al.  Celecoxib has a positive effect on the overall metabolism of hyaluronan and proteoglycans in human osteoarthritic cartilage. , 2003, The Journal of rheumatology.

[12]  R. Ramer,et al.  Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac , 2003, Clinical pharmacology and therapeutics.

[13]  M. Schulz,et al.  Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. , 2003, Die Pharmazie.

[14]  I. Morita.  Distinct functions of COX-1 and COX-2. , 2002, Prostaglandins & other lipid mediators.

[15]  R. Langenbach,et al.  Phenotypes of the COX-deficient mice indicate physiological and pathophysiological roles for COX-1 and COX-2. , 2002, Prostaglandins & other lipid mediators.

[16]  M. Currie,et al.  Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. , 2002, Arthritis and rheumatism.

[17]  J. Bijlsma,et al.  Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage. , 2002, Rheumatology.

[18]  C. Ding.  Do NSAIDs Affect the Progression of Osteoarthritis? , 2002, Inflammation.

[19]  F. López-Muñoz,et al.  Involvement of peripheral cyclooxygenase‐1 and cyclooxygenase‐2 in inflammatory pain , 2002, The Journal of pharmacy and pharmacology.

[20]  Gerd Geisslinger,et al.  Cyclooxygenase‐independent actions of cyclooxygenase inhibitors , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  Y. Henrotin,et al.  In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators , 2001, Inflammation Research.

[22]  A. Hungin,et al.  Nonsteroidal anti-inflammatory drugs: overused or underused in osteoarthritis? , 2001, The American journal of medicine.

[23]  J. Pelletier,et al.  Carprofen simultaneously reduces progression of morphological changes in cartilage and subchondral bone in experimental dog osteoarthritis. , 2000, The Journal of rheumatology.

[24]  J. Devogelaer,et al.  Effects of diclofenac, aceclofenac and meloxicam on the metabolism of proteoglycans and hyaluronan in osteoarthritic human cartilage , 2000, British journal of pharmacology.

[25]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[26]  M. Goldring,et al.  The role of the chondrocyte in osteoarthritis. , 2000, Arthritis and rheumatism.

[27]  R. Bible,et al.  Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers , 2000 .

[28]  R. Gaynor,et al.  Sulindac Inhibits Activation of the NF-κB Pathway* , 1999, The Journal of Biological Chemistry.

[29]  R. Langenbach,et al.  Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts , 1999, The Journal of experimental medicine.

[30]  J. Vane,et al.  Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[31]  G. Weissmann,et al.  Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Umberto Serni,et al.  Is there preliminary in-vivo evidence for an influence of nonsteroidal antiinflammatory drugs on progression in osteoarthritis? Part II-evidence from animal models. , 1999, Osteoarthritis and cartilage.

[33]  J. Dingle.  The effect of nonsteroidal antiinflammatory drugs on human articular cartilage glycosaminoglycan synthesis. , 1999, Osteoarthritis and cartilage.

[34]  J. Reginster,et al.  In-vitro differences among nonsteroidal antiinflammatory drugs in their activities related to osteoarthritis pathophysiology. , 1999, Osteoarthritis and cartilage.

[35]  J. Vane,et al.  Mechanism of action of nonsteroidal anti-inflammatory drugs. , 1998, The American journal of medicine.

[36]  Weiya Ma,et al.  Inhibition of Ultraviolet B-induced Activator Protein-1 (AP-1) Activity by Aspirin in AP-1-Luciferase Transgenic Mice* , 1997, The Journal of Biological Chemistry.

[37]  T. Koshino,et al.  Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. , 1997, European journal of pharmacology.

[38]  J. Lehmann,et al.  Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.

[39]  I. Otterness,et al.  Effects of tenidap on the progression of osteoarthritic lesions in a canine experimental model. Suppression of metalloprotease and interleukin-1 activity. , 1997, Arthritis and rheumatism.

[40]  X. Ponsoda,et al.  Comparative metabolism of the nonsteroidal antiinflammatory drug, aceclofenac, in the rat, monkey, and human. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[41]  X. Ponsoda,et al.  Metabolism of aceclofenac in humans. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[42]  E. D. Murray,et al.  Antiproliferative Effects of the Enantiomers of Flurbiprofen , 1996, Journal of clinical pharmacology.

[43]  F. Luscinskas,et al.  Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. , 1996, Journal of immunology.

[44]  N. Mackman,et al.  Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells. , 1995, Blood.

[45]  B. Rigas,et al.  Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells. , 1995, The Journal of clinical investigation.

[46]  N. Lane,et al.  Nonsteroidal antiinflammatory drugs: effects on normal and interleukin 1 treated human articular chondrocyte metabolism in vitro. , 1995, The Journal of rheumatology.

[47]  W. Erl,et al.  Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells. , 1995, Circulation.

[48]  F. Lafeber,et al.  Osteoarthritic human cartilage is more sensitive to transforming growth factor beta than is normal cartilage. , 1993, British journal of rheumatology.

[49]  V. Mow,et al.  In vivo effects of naproxen on composition, proteoglycan metabolism, and matrix metalloproteinase activities in canine articular cartilage , 1993, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[50]  F. Lafeber,et al.  Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. , 1992, The American journal of pathology.

[51]  S. Collier,et al.  Comparison of the effects of non-steroidal anti-inflammatory drugs (NSAIDs) on proteoglycan synthesis by articular cartilage explant and chondrocyte monolayer cultures. , 1991, Biochemical pharmacology.

[52]  Brandt Kd.  The mechanism of action of nonsteroidal antiinflammatory drugs. , 1991 .

[53]  P. Whiteman.  The quantitative determination of glycosaminoglycans in urine with Alcian Blue 8GX. , 1973, The Biochemical journal.

[54]  H. Dorfman,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. , 1971, The Journal of bone and joint surgery. American volume.

[55]  H J Mankin,et al.  Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. , 1970, The Journal of bone and joint surgery. American volume.

[56]  P. Aisen,et al.  Non-steroidal anti-inflammatory drugs protect against chondrocyte apoptotic death. , 2001, Clinical and experimental rheumatology.

[57]  R. Bible,et al.  Metabolism and excretion of [(14)C]celecoxib in healthy male volunteers. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[58]  R. Gaynor,et al.  Sulindac inhibits activation of the NF-kappaB pathway. , 1999, The Journal of biological chemistry.

[59]  J. Lehmann,et al.  Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. , 1997, The Journal of biological chemistry.

[60]  F. Lafeber,et al.  Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. , 1993, Connective tissue research.

[61]  E. Vignon,et al.  Effect of non-steroidal anti-inflammatory drugs (NSAIDS) on glycosyltransferase activity from human osteoarthritic cartilage. , 1992, British journal of rheumatology.

[62]  C. Deighton,et al.  Rheumatoid arthritis in thyroid disease positive and negative same-sexed sibships. , 1992, British journal of rheumatology.

[63]  K. Brandt.  The mechanism of action of nonsteroidal antiinflammatory drugs. , 1991, The Journal of rheumatology. Supplement.